Results 131 to 140 of about 120,914 (222)

Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients. [PDF]

open access: yesAm J Hematol
Molica M   +41 more
europepmc   +1 more source

Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy. [PDF]

open access: yesBlood Adv
Othman J   +35 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy